MWNA
RNA

Marshall Wace North America’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Marshall Wace North America’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$16K Sell
3,509
-11,491
-77% -$52.4K ﹤0.01% 679
2013
Q3 		$99K Buy
+15,000
New +$353K ﹤0.01% 590

Other funds holding RNA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Marshall Wace North America's RNA Position: Q4 2013 in Review

Marshall Wace North America reduced its PROSENSA HLDGS N V ORD SHS (NLD) (RNA) stake by 77% in Q4 2013, selling an estimated $52.4K and leaving 3,509 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Marshall Wace North America first reported a position in RNA in Q3 2013 and has held it in 2 quarters since. The position peaked at $99K in Q3 2013. 22 funds tracked by Wall St. Rank hold RNA as of Q4 2013.

  • Marshall Wace North America held 3,509 shares of PROSENSA HLDGS N V ORD SHS (NLD) worth $16K as of Q4 2013.
  • Marshall Wace North America sold 11,491 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2013, an estimated $52.4K.
  • PROSENSA HLDGS N V ORD SHS (NLD) made up ﹤0.01% of Marshall Wace North America's portfolio in Q4 2013, its #679 holding.
  • Marshall Wace North America first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and has held it in 2 quarters since.
  • Marshall Wace North America's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $99K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.